Exosomes in cancer metabolism and drug resistance: A review
Biomolecules and Biomedicine · 05.11.2025 · 26 (5) · 730-745
DOI: 10.17305/bb.2025.13295 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 05.11.2025. Verfasst von Ousman Mohammed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; Department of Medi…. Hauptthemen laut MEDLINE: Exosomes, Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The transfer of molecular cargo in exosomes plays a crucial role in cancer progression, influencing metabolic processes, angiogenesis, immune interactions, and invasive capabilities. This review synthesizes current evidence on how exosomes modulate tumor metabolism and drive drug resistance, and outlines therapeutic opportunities. We searched PubMed, Scopus, Web of Science, and Google Scholar for English-language studies using terms related to exosomes/extracellular vesicles, glycolysis, oxidative phosphorylation (OXPHOS), lipid metabolism, and drug resistance/chemoresistance, and integrated the literature qualitatively. Evidence indicates that exosomes reprogram tumor and stromal metabolism by delivering enzymes and non-coding RNAs that boost glycolysis and dampen OXPHOS, activate cancer-associated fibroblasts and extracellular matrix (ECM) remodeling, and modulate ferroptosis. They stimulate angiogenesis (e.g., via vascular endothelial growth factor (VEGF)/Wnt pathways) and promote immune escape through programmed death-ligand 1 (PD-L1), transforming growth factor beta (TGF-β), and macrophage reprogramming. Exosomal integrins and proteases contribute to epithelial–mesenchymal transition (EMT), organotropism, and pre-metastatic niche formation. Critically, exosomes propagate chemoresistance by exporting drugs and spreading determinants—including P-gp/BCRP/MRP-1, anti-apoptotic proteins, and regulatory RNAs—to previously sensitive cells; adipose-derived vesicles and lipid cargos further reinforce metabolic plasticity and therapy resistance. Given their stability, nanoscale dimensions, and ability to cross the blood–brain barrier, exosomes are promising vectors for targeted delivery; engineered vesicles can enhance chemotherapy responsiveness and counteract resistance, particularly alongside immunotherapy. In summary, interventions that disrupt exosome biogenesis, cargo loading, or uptake—paired with engineered exosomes for precision delivery—could mitigate drug resistance, metastasis, and immune evasion and advance more effective cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Woll…
- Department of Medical Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis A…
- Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
- Department of Medical Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Zitieren
APA
Mohammed, O., Ahmed Assaye, M., Alemayehu, E., Tufa, A., & Genet, S. (2025). Exosomes in cancer metabolism and drug resistance: A review. Biomolecules and Biomedicine, 26(5), 730-745. https://doi.org/10.17305/bb.2025.13295
Vancouver
Mohammed O, Ahmed Assaye M, Alemayehu E, Tufa A, Genet S. Exosomes in cancer metabolism and drug resistance: A review. Biomolecules and Biomedicine. 2025;26(5):730-745. doi:10.17305/bb.2025.13295
BibTeX
@article{Mohammed2025,
author = {Mohammed, Ousman and Ahmed Assaye, Masresha and Alemayehu, Ermiyas and Tufa, Abdisa and Genet, Solomon},
title = {Exosomes in cancer metabolism and drug resistance: A review},
journal = {Biomolecules and Biomedicine},
year = {2025},
volume = {26},
number = {5},
pages = {730--745},
doi = {10.17305/bb.2025.13295}
}
EUVIMED